PBLS compared with SGP: revenue, margins and what each company keeps, and the suppliers and customers both name

PBLSParabilis Medicines, Inc.

Mkt capRevenueRevenue

SGPSpyGlass Pharma, Inc.

Mkt capRevenueRevenue

Compare

PBLSParabilis Medicines, Inc.

SGPSpyGlass Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PBLS 2

REGNRegeneron Pharmaceuticalscustomer

—Alcamiunlistedsupplier

Shared 0

No shared counterparties.

Only SGP 1

—Regents of the University of Colorado (CU)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PBLSParabilis Medicines, Inc.

28.58▲+2.50%· post 28.58· delayed

Mkt cap$824.8MRevenue$148,000Q2 FY26

SGPSpyGlass Pharma, Inc.

36.20▲+6.22%· post 36.21· delayed

After hoursNov 6 '26delayed

Mkt cap$1.2BRevenue—

Compare

After hoursNov 6 '26delayed

PBLSParabilis Medicines, Inc.

SGPSpyGlass Pharma, Inc.

28.58▲+2.50%post 28.58delayed

Price

36.20▲+6.22%post 36.21delayed

$824.8M

Mkt cap

$1.2B

Q2 FY26$148,000

Revenue

—

PBLS28.58▲+2.50%vsSGP36.20▲+6.22%After hoursNov 6 '26delayed